{
  "id": 1806,
  "text": "It should be noted that no differences in the site and pattern of disease recurrence were observed between the two treatments.Another identified study1713 evaluated the efficacy of CCRT with curative intent in patients with FIGO stage IVB cervical cancer initially presenting with para-aortic and left supraclavicular LN metastases (groupe I) and compared these findings with those in patients with PALN without left supraclavicular LN metastases who received extended-field CCRT (group II).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: It should be noted that no differences in the site and pattern of disease recurrence were observed between the two treatments.Another identified study1713 evaluated the efficacy of CCRT with curative intent in patients with FIGO stage IVB cervical cancer initially presenting with para-aortic and left supraclavicular LN metastases (groupe I) and compared these findings with those in patients with P\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于FIGO IVB期宫颈癌同时出现主动脉旁及左锁骨上淋巴结转移的患者，研究表明，无论是针对这种情况的以根治为目的的同步放化疗（CCRT），还是单纯涉及主动脉旁淋巴结扩展野的CCRT，疾病复发的部位和模式上没有明显差异。这提示这些治疗方法在控制疾病方面具有相似的效果。",
  "query": "对于FIGO IVB期宫颈癌患者，同时出现主动脉旁及左锁骨上淋巴结转移的情况，哪些治疗方法在疾病复发的部位和模式上没有明显差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于FIGO IVB期宫颈癌患者，同时出现主动脉旁及左锁骨上淋巴结转移的情况，哪些治疗方法在疾病复发的部位和模式上没有明显差异？\n\n<reference text>: It should be noted that no differences in the site and pattern of disease recurrence were observed between the two treatments.Another identified study1713 evaluated the efficacy of CCRT with curative intent in patients with FIGO stage IVB cervical cancer initially presenting with para-aortic and left supraclavicular LN metastases (groupe I) and compared these findings with those in patients with PALN without left supraclavicular LN metastases who received extended-field CCRT (group II).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于FIGO IVB期宫颈癌同时出现主动脉旁及左锁骨上淋巴结转移的患者，研究表明，无论是针对这种情况的以根治为目的的同步放化疗（CCRT），还是单纯涉及主动脉旁淋巴结扩展野的CCRT，疾病复发的部位和模式上没有明显差异。这提示这些治疗方法在控制疾病方面具有相似的效果。"
}